Prior to use of estrogen replacement therapy, are users healthier than nonusers?

American Journal of Epidemiology

Volumn 143, Issue 10, 1996, Pages 971-978

  Matthews, Karen A ^a   Kuller, Lewis H ^b   Wing, Rena R ^a   Meilahn, Elaine N ^b   Plantinga, Pamela ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

cardiovascular diseases; estrogen replacement therapy; menopause; risk factors

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; ESTROGEN; GESTAGEN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY RISK; DIASTOLIC BLOOD PRESSURE; ESTROGEN THERAPY; FEMALE; FITNESS; FOLLOW UP; HUMAN; INSULIN BLOOD LEVEL; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MENOPAUSE; ORAL DRUG ADMINISTRATION; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRANSDERMAL DRUG ADMINISTRATION; TREATMENT OUTCOME; TYPE A BEHAVIOR;

EID: 0029988657     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a008678     Document Type: Article

References (38)

1. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease. JAMA 1991;265:1861-7.
2. Manson JE, Tosteson H, Ridker PM, et al. The primary prevention of myocardial infarction. N Engl J Med 1992;326: 1406-16.
3. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-37.
4. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991:20:47-63.
5. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 1995;273:199-208.
6. Matthews KA, Meilahn E, Kuller LH, et al. Menopause and risk factors for coronary heart disease. N Engl J Med 1989; 321:641-6.
7. Hjortland MC, McNamara PM, Kennel WB. Some atherogenic concomitants of menopause: the Framingham Study. Am J Epidemiol 1976;103:304-11.
8. Nabulsi AA, Folsom AR, White A, et al. Association of hormone replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 1993;328: 1069-75.
9. Reis SE, Gloth ST, Blumenthal RS, et al. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 1994;89: 52-60.
10. Egeland GE, Matthews KA, Kuller LH, et al. Characteristics of noncontraceptive hormone users. Prev Med 1988;17: 403-11.
11. Cauley JA, Cummings SR, Black DM, et al. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol 1990;163:1438-44.
12. Manson JE, Stampfer MJ, Hennekens CH, et al. Body weight and longevity: a reassessment. JAMA 1987;257:353-8.
13. Kitagawa EM, Hauser PM. Differential mortality in the United States, a study in socioeconomic epidemiology. Cambridge, MA: Harvard University Press, 1973.
14. Matthews KA, Kelsey SF, Meilahn EN, et al. Educational attainment and behavioral and biologic risk factors for coronary heart disease in middle-aged women. Am J Epidemiol 1989;129:1132-44.
15. Garrow JS. Zero-muddler for unprejudiced sphygmomanometry. Lancet 1963;2:1205.
16. Dischinger P, DuChene AG. Quality control aspects of blood pressure measurements in the Multiple Risk Factor Intervention Trial. Control Clin Trials 1986;7(suppl):137S-57S.
17. Paffenbarger RS Jr, Wing AL, Hyde RT. Physical activity as an index of heart attack risk in college alumni. Am J Epidemiol 1978;108:161-75.
18. Beck AT, Beamesderfer A. Assessment of depression: the depression inventory. In: Pinchot P, ed. Psychological measurements in psychopharmacology. Vol. 7. Basel: Karger Press, 1974:151-69.
19. Cohen S, Kamarck TW, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983;24:385-96.
20. Neugarten BL, Kraines RD. "Menopausal symptoms" in women of various ages. Psychosom Med 1964;27:266-73.
21. Fenigstein A, Scheier MF, Buss AH. Public and private self consciousness: assessment and theory. J Cons Clin Psychol 1975;43:522-7.
22. Bortner RW. A short rating scale as a potential measure of Pattern A behavior. J Chronic Dis 1969;22:87-91.
23. Caplan RD, Cobb S, French JRP Jr, et al. Job demands and worker health: main effects and occupational differences. Ann Arbor, MI: Institute for Social Research, 1980.
24. Allain CC, Poon LS, Chan CS, et al. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-5.
25. Warnick GR, Alberts JJ. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res 1978;19: 65-76.
26. Gidez LI, Miller GJ, Burstein M, et al. Analyses of plasma high density lipoprotein subclasses by a precipitation procedure: correlations with preparative and analytical centrifugation. In: Lippel K, ed. Report of the High Density Lipoprotein Methodology Workshop, San Francisco, California, March 12, 13, and 14, 1979. Bethesda, MD: Department of Health, Education, and Welfare, NIH, 1979:328-42. (NIH publication no. 79-1661).
27. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973; 19: 476-82.
28. Stein EA, DiPersio L, Pesce AJ, et al. Enzyme-linked immunoabsorbent assay of apolipoprotein All in plasma, with use of a monoclonal antibody. Clin Chem 1986;32:967-71.
29. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
30. Herbert V, Lauk K-S, Gottlieb CW, et al. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 1965;25: 1375-84.
31. Wing RR, Bunker CH, Kuller LH, et al. Insulin, body mass index and cardiovascular risk factors in premenopausal women. Arteriosclerosis 1989;9:479-84.
32. Speroff L, Glass RH, Kase NG. Clinical gynecologic endocrinology and infertility. Baltimore: Williams & Wilkins, 1983.
33. Eaker ED, Pinsky J, Castelli WP. Myocardial infarction and coronary death among women: psychosocial predictors from a 20-year follow-up of women in the Framingham Study. Am J Epidemiol 1992;135:854-64.
34. Kamarck T, Jennings JR. Behavioral factors in sudden cardiac death. Psychol Bull 1991;109:42-75.
35. Gordon DJ, Probstfield JL, Garrison RJ, et al. High density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation 1989;79:8-15.
36. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease: part 2. short-term reductions in blood pressure: overview of randomized drug trials in their epidemiologic context. Lancet 1990;335:827-38.
37. Herzog HD, Sutton-Tyrell K, Matthews KA, et al. Risk factors for carotid plaque in women pre and postmenopause. (Abstract). Circulation 1995;91:935.
38. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease. N Engl J Med 1991;325:756-62.